Rikke B. Holmstroem
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis.
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Safety and feasibility of blood-derived multiple antigen-specific endogenously derived T cells (MASE-T) for metastatic melanoma.
Journal: Immuno-oncology technology
Published: January 23, 2026
Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.
Journal: Cell reports. Medicine
Published: August 29, 2024
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcome.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 18, 2024
Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 13, 2023
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 16, 2023
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
Journal: Frontiers in immunology
Published: December 13, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: December 08, 2022
Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial.
Journal: Frontiers in immunology
Published: August 19, 2022
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
Journal: Journal for immunotherapy of cancer
Published: July 11, 2022
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Journal: Nature medicine
Published: March 09, 2022
Last Updated: 09/26/2026